These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 711613)

  • 1. Comparative in vitro activity of a semisynthetic derivative of gentamicin B (SCH 21420) and five other aminoglycosides.
    Watanakunakorn C
    J Antibiot (Tokyo); 1978 Oct; 31(10):1063-4. PubMed ID: 711613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activity of various semisynthetic aminoglycoside antibiotics on gentamicin-sensitive and gentamicin-resistant bacterial populations].
    Zemelman R; Bello H; Mondaca MA
    Rev Med Chil; 1983 Mar; 111(3):255-61. PubMed ID: 6648106
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin.
    Ries K; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Apr; 3(4):532-3. PubMed ID: 4790607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotics and ERCP: in vitro activity of aminoglycosides when added to iodinated contrast agents.
    Jendrzejewski JW; McAnally T; Jones SR; Katon RM
    Gastroenterology; 1980 Apr; 78(4):745-8. PubMed ID: 7353761
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
    Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
    Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective growth of resistant variants during incubation of Enterobacteriaceae with four aminoglycosides.
    Nilsson L; Sörén L
    J Antimicrob Chemother; 1986 Sep; 18(3):317-24. PubMed ID: 3771425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A growing clinical problem: plasmid-determined resistance to aminocyclitol-aminoglycosides in enterobacteria.
    Gómez-Lus R; Rivera MJ; Vitoria MA
    Chemioterapia; 1984 Dec; 3(6):368-70. PubMed ID: 6099225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of netilmicin against selected strains of Gram-negative bacteria and Staphylococcus aureus: comparison with four other aminoglycosides.
    Mouton RP; de Kok-Broeren MC
    J Antimicrob Chemother; 1977 Sep; 3(5):393-401. PubMed ID: 903322
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of netilmicin (SCH 20569) against bacterial isolates from ill children.
    Greenstone G; Hammerberg S; Marks MI
    Chemotherapy; 1978; 24(1):29-33. PubMed ID: 412647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity of bacteria to netilmicin in comparison with their sensitivity to gentamicin and other aminoglycosides].
    Ruczkowska J; Dolna I
    Przegl Lek; 1988; 45(4):383-6. PubMed ID: 3145533
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of clinical isolates to dactimicin and gentamicin.
    Bergan T
    Drugs Exp Clin Res; 1989; 15(3):109-12. PubMed ID: 2752907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibacterial activity of tobramycin on enterobacteria. Present aspects of resistance factors].
    Witchitz J
    Nouv Presse Med; 1974 Apr; 3(0):43-6. PubMed ID: 4837114
    [No Abstract]   [Full Text] [Related]  

  • 16. 1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
    Neu HC; Fu KP
    J Antibiot (Tokyo); 1978 May; 31(5):385-93. PubMed ID: 27494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
    Husson MO; Izard D; Bryskier A; Vincent P; Leclerc H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):383-7. PubMed ID: 6091368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
    Van der Auwera P
    J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.